Stryker Corporation (SYK)
Stryker Corporation operates as a medical technology company in the United States and internationally.
Scored against other Healthcare stocks, not a fixed scale.
The quick read
Stryker reads as neutral right now, with no clear lean either way.
- What's working
- Sales and profits grew faster over the past year than at most other healthcare companies.
- Worth watching
- Its price has been falling, trading below its recent averages.
Analyst price target
~12-month · 26 analystsPublished targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics…
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 56,000
- Headquarters
- Portage, MI
Similar stocks
What’s behind the score
Valuation
P/E 30.5 — lower than 54% of Healthcare peers
P/B 4.7 — lower than 43% of Healthcare peers
P/S 4.4 — lower than 50% of Healthcare peers
EV/EBITDA 16.9 — lower than 37% of Healthcare peers
EV/Revenue 4.8 — lower than 47% of Healthcare peers
PEG 1.4 — lower than 56% of Healthcare peers
FCF yield 3.6% — higher than 38% of Healthcare peers
Profitability & quality
Gross margin 65.6% — higher than 57% of Healthcare peers
Operating margin 27.0% — higher than 63% of Healthcare peers
Net margin 14.4% — higher than 57% of Healthcare peers
ROE 16.5% — higher than 70% of Healthcare peers
ROA 8.2% — higher than 59% of Healthcare peers
Free cash flow is 110% of reported net income
Financial health
Debt/equity 0.6 — lower than 52% of Healthcare peers
Current ratio 2.16 — higher than 83% of Healthcare peers
Quick ratio 1.08 — higher than 62% of Healthcare peers
Cash/debt 0.23 — higher than 55% of Healthcare peers
Debt/EBITDA 2.09 — lower than 62% of Healthcare peers
Growth
Revenue growth 9.4% YoY — higher than 53% of Healthcare peers
Earnings growth 44.1% YoY — higher than 77% of Healthcare peers
Ownership & investor activity
Payout ratio 36.1% — typical for Healthcare peers
Net insider selling, -3.0% of insider shares
Institutions net sold, -9.4% of shares held
Insiders hold 5.4% of shares outstanding
1.6% of float sold short
Momentum
Below its 50- & 200-day averages
22% of the way from its 52-week low to high